Logo - springer
Slogan - springer

Springer Healthcare | Neurology and Therapy (Editorial Board)

Neurology and Therapy

Neurology and Therapy

ISSN: 2193-6536 (electronic version)

Journal no. 40120

Editorial Board

Alon Y. Avidan, UCLA David Geffen School of Medicine, Los Angeles, USA
Yoram Barak, Sackler School of Medicine, Tel-Aviv University, Israel
Natan Bornstein, University Tel Aviv, Israel
Cris S Constantinescu, University of Nottingham School of Medicine, Nottingham, UK
Stefan Evers, Krankenhaus Lindenbrunn, Coppenbrügge, Germany
Paul T. Francis, King’s College London, London, UK
Sten Fredrikson, Karolinska Institute, Stockholm, Sweden
Giovanni B. Frisoni, IRCCS Fatebenefratelli, Brescia, Italy
Samuel Gandy, Mount Sinai Hospital, New York, USA
Hans-Peter Hartung, Heinrich Heine University Dusseldorf, Germany
Reinhard Hohlfeld, Ludwig Maximilian University, Munich, Germany
Bernd C. Kieseier, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany
Christine Lebrun Frenay, Pasteur Hospital, Nice, France
Ronald P. Lesser, The Johns Hopkins Hospital, Maryland, USA
Thomas Müller,St. Joseph Hospital Berlin-Weissensee, Berlin, Germany
Mark Obermann, University of Duisburg-Essen, Essen, Germany
Olivier Rascol, University Hospital of Toulouse, Toulouse, France
Heinz Reichmann, University of Dresden, Dresden, Germany
Tony Schapira, University College London, London, UK
Eugen Trinka, Paracelsus Medical University, Salzburg, Austria
Pablo Villoslada, Institute of Biomedical Research August Pi Sunyer Hospital Clinic Barcelona, Barcelona, Spain

Advisory Board

Brandon R. Barton, Charly Gaul, Angelo Ghezzi, Katherine McMillan, Paul Newhouse, Iris-Katharina Penner, Patricio Riva Posse, Jaume Sastre-Garriga, François Tison, Kayihan Uluc, Zhongya Wang, Michael Zvolensky

 

Articles

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Neurology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of neurological therapies. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.

    Areas of focus include, but are not limited to, anesthetics, analgesics, anticonvulsants, antidepressants, antipsychotics, hypnotics/sedatives, mood stabilizers, stimulants, neurosurgery, behavior and addiction, and developmental disorders.

    The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world.

    Moving forward from traditional publishing, Neurology and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include slide sets, videos, animations, and/or interactive learning resources. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

    Neurology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/2.5.

    Upon acceptance of your article for publication, you will be required to pay the article processing charge of £210/€250/$320 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.

    For more information about the journal, please contact lee.kettley@springer.com or see the News page for the latest journal offers.

  • Submit Online
  • Instructions for Authors (pdf, 267 kB)
  • Author Disclosure form (pdf, 131 kB)
  • Compliance with Ethical Policies
  • Author Academy: Training for Authors
  • Copyright information

    Copyright information

    Close

    Copyright Information

    Open Access Neurology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0

    Journal ownership: Springer Healthcare

    Copyright of articles: © The Author(s)

Alerts for this journal

 

Get the table of contents of every new issue published in Neurology and Therapy.